Results 81 to 90 of about 176,903 (205)

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

open access: yesAmerican Journal of Hematology, Volume 101, Issue 9, Page 2177-2189, September 2026.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez   +17 more
wiley   +1 more source

Real‐Life Study on Gilteritinib‐Related Infections (GilteRInf): An Italian SEIFEM Study

open access: yes
American Journal of Hematology, Volume 101, Issue 10, Page 2672-2676, October 2026.
Elisa Buzzatti   +25 more
wiley   +1 more source

Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis [PDF]

open access: yes
Weiran Li, Mao Hua, Jin Guo, Wenbo Jia Department of Clinical Medicine, School of Medicine, Qinghai University, Xining, People’s Republic of ChinaCorrespondence: Mao Hua, Qinghai University Affiliated Hospital, No.
Li W, Guo J, Jia W, Hua M
core  

Post-COVID-19 severe pneumonia in a non-HIV and immunocompetent patient: A case report and literature review

open access: yesJournal of International Medical Research
Pneumocystis jirovecii is a ubiquitous opportunistic fungus that can cause life-threatening pneumonia. The clinical manifestations of pneumonia caused by severe acute respiratory syndrome coronavirus 2 and P.
Zhi-Yang Xu   +4 more
doaj   +1 more source

Pneumocystis jirovecii pneumonia-Immune reconstitution inflammatory syndrome: A review of published cases. [PDF]

open access: yesHIV Med
Background Immune reconstitution inflammatory syndrome (IRIS) can occur in patients with HIV after commencing antiretroviral therapy. Tuberculosis–IRIS is the most common, and Pneumocystis jirovecii pneumonia (PJP)–IRIS accounts for only 2.7%–4% of IRIS ...
Vaselli NM   +3 more
europepmc   +2 more sources

Advances in pathogen detection of <i>Pneumocystis jirovecii</i> pneumonia. [PDF]

open access: yesInfect Med (Beijing)
Pneumocystis jirovecii pneumonia (PJP) is a life-threatening opportunistic fungal infection in immunocompromised populations. Microscopic identification of P. jirovecii cysts or trophozoites in lower respiratory specimens remains the diagnostic gold standard.
Bai L, Li Y, Li Y, Hu C, Zhao B.
europepmc   +3 more sources

Cavitary Pneumocystis jirovecii pneumonia [PDF]

open access: yesQJM: An International Journal of Medicine, 2021
R, MacCann   +5 more
openaire   +2 more sources

Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts

open access: yesNature Communications, 2016
Pneumocystis jirovecii is a fungus that can cause life-threatening pneumonia in immunocompromised patients. Here, the authors sequence the genomes of P.
Liang Ma   +43 more
doaj   +1 more source

A case of spontaneous pneumothorax, pneumomediastinum & subcutaneous emphysema in Pneumocystis jirovecii pneumonia complicating HIV

open access: yesSri Lankan Journal of Infectious Diseases, 2015
Spontaneous pneumothorax and subcutaneous emphysema are well-known but less common complications of pneumocystis pneumonia, whereas pnuemomediastinum is rare.
S Chatterji   +6 more
doaj   +1 more source

Immune reconstitution inflammatory syndrome associated with pneumonia in a patient with AIDS

open access: yesJournal of International Medical Research, 2020
Immune reconstitution inflammatory syndrome (IRIS) after starting antiretroviral treatment for human immunodeficiency virus (HIV) infection has a wide variety of causes. Delayed diagnosis and treatment of IRIS is fatal.
Ying Wen   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy